In Vitro Methods in Pharmaceutical Research

D.W. Straughan, J.H. Fentem, and M. Balls, Replacement Alternative and Complementary In Vitro Methods in Pharamaceutical Research.<br>M.D. Barratt and M. Chamberlain, Integration of QSAR and In Vitro Toxicology.<br>F.A. Barile, Continuous Cell Lines as a Model for Drug Toxicity Assessment.<br>P. Bach, In Vitro Models for Nephrotoxicity Studies.<br>A.E.M. Vickers, Experimental In Vitro Models to Evaluate Hepatotoxicity.<br>M.J. Gomez-Lechon, T. Donato, X. Ponsoda, R. Fabra, R. Trullenque, and J.V. Castell, Isolation, Culture and Use of Human Hepatocytes in Drug Research.<br>E. McFarlane-Abdulla, and I.C. Campbell, Studies of Nephrotoxicity in Cellular Studies.<br>M. Adolphe, S. Thenet-Gauci, and S. Demignot, Chondrocyte Culture: A Target System to Evaluate Pharmaco-Toxicological Effects of Drugs.<br>E. Chacon, D. Acosta, and J.J. Lemasters, Primary Cultures of Cardiac Myocytes as In Vitro Models for Pharmacological andToxicological Assessments.<br>R. Roguet, Cutaneous Pharmacotoxicology In Vitro.<br>H. Spielmann, Ocular Irritation.<br>M.A. Miranda, Phototoxicity of Drugs.<br>I. de G. Mitchell and R.D. Combes, In Vitro Genotoxicity and Cell Transformation Assessment.<br>B. Schmid, R. Bechter, and P. Kucera, The Use of Whole Embryo Cultures in In Vitro Teratogenicity Testing.<br>J.V. Castell, M.J. Gomez-Lechon, X. Ponsoda, and R. Bort, In Vitro Investigation of the Molecular Mechanisms of Hepatotoxicity.<br>A. Guillouzo, Biotransformation of Drugs by Hepatocytes.<br>K. Mace, E.A. Offord, and A.M.A. Pfeifer, Drug Metabolism and Carcinogen Activation Studies with Human Genetically Engineered Cells.